RxDoctor Payments Data

Ghislaine Fougy, MD

Psychiatry · Silver Spring, MDNPI 1689787079

Payments from drug & device makers

$2,389in general payments, 2019–2025

Across 137 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$522
  • Vanda Pharmaceuticals Inc.$462
  • Sunovion Pharmaceuticals Inc.$315
  • Teva Pharmaceuticals USA, Inc.$253
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$195
  • Alkermes, Inc.$190
  • plus $453 from 9 others

What the payments were for

  • Food & beverage$2,28996%
  • Education$1014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,389 in reported general payments places this provider in the 85th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland

Medicare billing

Part B allowed, 2024
$84,857
Medicare patients
84
Services billed
948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine14$85,563
VraylarCariprazine Hcl31$54,472
TrintellixVortioxetine Hydrobromide14$17,457
Aripiprazole50$12,883
RisperdalRisperidone14$11,503
Lurasidone Hcl18$11,220
LexaproEscitalopram Oxalate12$5,210
Quetiapine Fumarate208$4,484
Buspirone Hcl159$2,875
Bupropion XlBupropion Hcl66$2,684
Divalproex Sodium ErDivalproex Sodium43$2,518
Oxcarbazepine42$2,058
Fluphenazine Hcl23$2,031
Thiothixene24$1,836
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine38$1,637

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$253$85,56314 claims
AbbVieVraylar, Lexapro$522$59,68243 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$17,45714 claims
Johnson & JohnsonRisperdal$22$11,50314 claims
Almatica Pharma LLCSertraline Hcl$30$40232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 851 psychiatry providers in Maryland.

Other psychiatry in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →